Veterinary Medicines

Belavit AD3E, Solution for Injection for Horses, Cattle, Pigs, and Dogs

Not authorised
  • Retinol palmitate
  • COLECALCIFEROL CONCENTRATE (OILY FORM)
  • DL-ALPHA TOCOPHEROL ACETATE
Download as PDF

Product identification

Medicine name:
Vitamin AD3E pro injectione, solution for injection for horses, cattle, pigs, and dogs
Belavit AD3E, Solution for Injection for Horses, Cattle, Pigs, and Dogs
Active substance:
  • Retinol palmitate
  • COLECALCIFEROL CONCENTRATE (OILY FORM)
  • DL-ALPHA TOCOPHEROL ACETATE
Target species:
  • Cattle
  • Dog
  • Horse
  • Pig
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Retinol palmitate
    176.46
    milligram(s)
    /
    1.00
    millilitre(s)
  • COLECALCIFEROL CONCENTRATE (OILY FORM)
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • DL-ALPHA TOCOPHEROL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        120
        hour
      • Meat and offal
        259
        day
    • Dog
    • Horse
      • Meat and offal
        250
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        194
        day
  • Intramuscular use
    • Cattle
      • Milk
        120
        hour
      • Meat and offal
        259
        day
    • Dog
    • Horse
      • Meat and offal
        250
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        194
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Expired
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • (ID3): 1 unspecified outer container with 12 Bottle (Glass) with 100 millilitre(s) (1200 millilitre(s))
  • (ID2): 1 unspecified outer container with 6 Bottle (Glass) with 100 millilitre(s) (600 millilitre(s))
  • (ID1): 1 unspecified outer container with 1 Bottle (Glass) with 100 millilitre(s) (100 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 41816/4004
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0313/001

Documents

Combined File of all Documents

English (PDF)
Published on: 15/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."